Balance Sheet
Cash Flow Statement
Daily Values
DMA 100DMA 200DMA 50Dividend YieldEV to EBITEV to EBITDAEV to FCFEnterprise ValueMarket Cap to FCFMarket CapitalizationPricePrice to Earnings
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Xtant Medical Holdings (XTNT) Enterprise Value (2016 - 2025)

Xtant Medical Holdings has reported Enterprise Value over the past 16 years, most recently at -$17.3 million for Q4 2025.

  • Quarterly Enterprise Value fell 178.54% to -$17.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$17.3 million through Dec 2025, down 178.54% year-over-year, with the annual reading at -$17.3 million for FY2025, 178.54% down from the prior year.
  • Enterprise Value was -$17.3 million for Q4 2025 at Xtant Medical Holdings, down from -$10.6 million in the prior quarter.
  • Over five years, Enterprise Value peaked at -$4.4 million in Q2 2023 and troughed at -$20.5 million in Q2 2021.
  • The 5-year median for Enterprise Value is -$9.7 million (2023), against an average of -$11.8 million.
  • Year-over-year, Enterprise Value tumbled 685.43% in 2021 and then soared 73.6% in 2023.
  • A 5-year view of Enterprise Value shows it stood at -$18.4 million in 2021, then decreased by 11.53% to -$20.5 million in 2022, then surged by 71.12% to -$5.9 million in 2023, then dropped by 5.03% to -$6.2 million in 2024, then tumbled by 178.54% to -$17.3 million in 2025.
  • Per Business Quant, the three most recent readings for XTNT's Enterprise Value are -$17.3 million (Q4 2025), -$10.6 million (Q3 2025), and -$7.0 million (Q2 2025).